Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA.

J Addict Med. 2013 Mar-Apr;7(2):102-7. doi: 10.1097/ADM.0b013e31827f9bdf.

2.

The medical management of opioid dependence in HIV primary care settings.

Lum PJ, Tulsky JP.

Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. Review.

PMID:
17089480
3.

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA.

Addiction. 2005 Feb;100(2):150-8. Review.

PMID:
15679744
4.

Antiretroviral (ARV) drug resistance in the developing world.

Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Tringle C, Mojica W, Newberry S.

Evid Rep Technol Assess (Full Rep). 2007 Sep;(156):1-74. Review.

5.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
6.

Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

Gruber VA, McCance-Katz EF.

Curr HIV/AIDS Rep. 2010 Aug;7(3):152-60. doi: 10.1007/s11904-010-0048-2. Review.

7.

Opioid agonist treatment for pharmaceutical opioid dependent people.

Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N.

Cochrane Database Syst Rev. 2016 May 9;(5):CD011117. doi: 10.1002/14651858.CD011117.pub2. Review.

PMID:
27157143
8.

Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.

Meemken L, Hanhoff N, Tseng A, Christensen S, Gillessen A.

Ann Pharmacother. 2015 Jul;49(7):796-807. doi: 10.1177/1060028015581848. Epub 2015 Apr 22. Review.

PMID:
25902733
9.

Illicit drugs, alcohol, and addiction in human immunodeficiency virus.

Samet JH, Walley AY, Bridden C.

Panminerva Med. 2007 Jun;49(2):67-77. Review.

PMID:
17625483
10.

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.

Bruce RD, Altice FL, Gourevitch MN, Friedland GH.

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):563-72. Review.

PMID:
16652030
11.

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Bruce RD, Moody DE, Altice FL, Gourevitch MN, Friedland GH.

Expert Rev Clin Pharmacol. 2013 May;6(3):249-69. doi: 10.1586/ecp.13.18. Review.

12.

Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145. doi: 10.1002/14651858.CD004145.pub4. Review.

PMID:
21833948
13.

Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review.

Mlunde LB, Sunguya BF, Mbwambo JK, Ubuguyu OS, Yasuoka J, Jimba M.

Int J Infect Dis. 2016 May;46:27-33. doi: 10.1016/j.ijid.2016.03.022. Epub 2016 Mar 29. Review.

14.

What do mathematical models tell us about the emergence and spread of drug-resistant HIV?

Baggaley RF, Powers KA, Boily MC.

Curr Opin HIV AIDS. 2011 Mar;6(2):131-40. doi: 10.1097/COH.0b013e328343ad03. Review.

15.

Drug treatment as HIV prevention: a research update.

Metzger DS, Woody GE, O'Brien CP.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S32-6. doi: 10.1097/QAI.0b013e3181f9c10b. Review.

16.

Drug treatment as HIV prevention: expanding treatment options.

Metzger DS, Zhang Y.

Curr HIV/AIDS Rep. 2010 Nov;7(4):220-5. doi: 10.1007/s11904-010-0059-z. Review.

18.

Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world.

Venkatesh KK, Flanigan TP, Mayer KH.

AIDS. 2011 Oct 23;25(16):1939-49. doi: 10.1097/QAD.0b013e32834b4ced. Review.

PMID:
21811137
19.

HIV treatment as prevention: contradictory perspectives from dynamic mathematical models.

Wu J, Norris JL, Jia Y, Wang N.

ScientificWorldJournal. 2014;2014:760734. doi: 10.1155/2014/760734. Epub 2014 Dec 15. Review.

20.

Hepatitis infection in the treatment of opioid dependence and abuse.

Kresina TF, Sylvestre D, Seeff L, Litwin AH, Hoffman K, Lubran R, Clark HW.

Subst Abuse. 2008 Apr 28;1:15-61. eCollection 2008. Review.

Supplemental Content

Support Center